masitinib, Placebo to 200mg masitinib, Placebo to 100mg masitinib, masitinib
AB19001
Phase 3 small_molecule active
Quick answer
masitinib, Placebo to 200mg masitinib, Placebo to 100mg masitinib, masitinib for Amyotrophic Lateral Sclerosis is a Phase 3 program (small_molecule) at AB Science with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AB Science
- Indication
- Amyotrophic Lateral Sclerosis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active